Dina Fine Maron, Editor of Health & Medicine at Scientific American, joins Cheddar to discuss some of the biggest changes to science regulations we'll see in 2018. From food labels to nonaddictive cigarettes, people need to be aware of what might affect their everyday lives.
A revamped nutrition label was slated to debut in July of 2018, however the Trump administration is giving companies a longer window. Major companies now have until 2020 and smaller companies have until 2021. The new labels will have more detail on added sugar and calorie count. However, critics say the delay could be a major blow to the public's health.
Plus, the U.S. Food and Drug Administration aims to create a nonaddictive cigarette with lower nicotine levels. It hopes this will help smokers quit. However, the agency opened up the conversation to the public for input which will ellicit some strong views from the tobacco industry.
On Monday, football fans were stunned when Buffalo Bills safety Damar Hamlin collapsed and suffered cardiac arrest. Cheddar News explains the condition and the steps to take if you witness an incident.
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
Join Cheddar News as we break down the top headlines this morning including updates on the Jan. 6 hears, the PGA suspension of 17 of the world's best golfers, and NASA's plans to study UFOs.
Rick Pauls, President & CEO OF DiaMedica Therapeutics, joins Cheddar Innovates to discuss a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients.
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
